Skip to Main Content

Paper Details

A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.
PLoS ONE
5
2021
CHOP, FGF-21, FSH, Fibroblast Growth Factor-21, Follicle-Stimulating Hormone, GRP78, GnRH, Gonadotropin-releasing, LH, Luteinizing Hormone, MIP-1, Macrophage Inflammatory Protein-1, Obesity, PARTICIPANTS, Participants, Reprometabolic syndrome, chronic inflammation, endocrine disruption, fatty acids, glucose, hyperinsulinemia, hyperlipidemia, hypogonadotropic hypogonadism, insulin, insulin resistance, interleukins, lipid, obesity, reproductive endocrine dysfunction, reprometabolic syndrome, steroids, woman, women
Author NameAffiliation
Nanette SantoroUniversity of Colorado School of Medicine
  • 1 - 1

Datasets

Release 1.2